{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T19:25:42Z","timestamp":1789500342351,"version":"build-2803163510"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1097\/aog.0b013e3181b76bea","type":"journal-article","created":{"date-parts":[[2009,9,16]],"date-time":"2009-09-16T03:14:10Z","timestamp":1253070850000},"page":"786-794","source":"Crossref","is-referenced-by-count":62,"title":["Effect of Injectable and Oral Contraceptives on Serum Lipids"],"prefix":"10.1097","volume":"114","author":[{"given":"Abbey B.","family":"Berenson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahbubur","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg","family":"Wilkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210126","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/0010-7824(91)90033-C","article-title":"Effect of depo-medroxyprogesterone acetate on coagulation factors and serum lipids in Egyptian women.","volume":"44","author":"Fahmy","year":"1991","journal-title":"Contraception"},{"key":"R2-13-20210126","first-page":"19","article-title":"Effects of prolonged use of injectable hormonal contraceptive on serum lipid profile.","volume":"14","author":"Mia","year":"2005","journal-title":"Mymensingh Med J"},{"key":"R3-13-20210126","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0010-7824(93)90090-T","article-title":"A multicentre comparative study of serum lipids and apolipoproteins in long-term users of DMPA and a control group of IUD users. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction.","volume":"47","author":"Kongsayreepong","year":"1993","journal-title":"Contraception"},{"key":"R4-13-20210126","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/0010-7824(93)90096-P","article-title":"Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.","volume":"47","author":"Oyelola","year":"1993","journal-title":"Contraception"},{"key":"R5-13-20210126","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0010-7824(76)90088-3","article-title":"A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive.","volume":"14","author":"Tankeyoon","year":"1976","journal-title":"Contraception"},{"key":"R6-13-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.contraception.2008.07.024","article-title":"Both a combined oral contraceptive and depot medroxyprogesterone acetate impair endothelial function in young women.","volume":"79","author":"Lizarelli","year":"2009","journal-title":"Contraception"},{"key":"R7-13-20210126","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0020-7292(86)90086-X","article-title":"Metabolic effects of depot-medroxyprogesterone acetate on long-term users: a cross-sectional study.","volume":"24","author":"Virutamasen","year":"1986","journal-title":"Int J Gynaecol Obstet"},{"key":"R8-13-20210126","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0010-7824(83)90087-2","article-title":"Alterations in blood lipids and side effects induced by depo-provera in Nigerian women.","volume":"27","author":"Fajumi","year":"1983","journal-title":"Contraception"},{"key":"R9-13-20210126","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/jbmr.5650100507","article-title":"Peak bone mass in young women.","volume":"10","author":"Teegarden","year":"1995","journal-title":"J Bone Miner Res"},{"key":"R10-13-20210126","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00016349109007886","article-title":"Serum lipids and lipoproteins during therapeutic amenorrhea induced by lynestrenol and depot-medroxyprogesterone acetate.","volume":"70","author":"Huovinen","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-13-20210126","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0010-7824(91)90106-P","article-title":"Long-term effects of depot medroxyprogesterone acetate on lipoprotein metabolism.","volume":"44","author":"Garza-Flores","year":"1991","journal-title":"Contraception"},{"key":"R12-13-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0010-7824(80)90007-4","article-title":"Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women.","volume":"21","author":"Amatayakul","year":"1980","journal-title":"Contraception"},{"key":"R13-13-20210126","first-page":"829","article-title":"Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results.","volume":"57","author":"Grossman","year":"1979","journal-title":"Bull World Health Organ"},{"key":"R14-13-20210126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0010-7824(85)90074-5","article-title":"Long-term effects of Depo-Provera on carbohydrate and lipid metabolism.","volume":"31","author":"Liew","year":"1985","journal-title":"Contraception"},{"key":"R15-13-20210126","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.contraception.2006.03.010","article-title":"Bone mineral density in women aged 25\u201335 years receiving depot medroxyprogesterone acetate: recovery following discontinuation.","volume":"74","author":"Kaunitz","year":"2006","journal-title":"Contraception"},{"key":"R16-13-20210126","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/S0002-9378(98)70291-1","article-title":"Metabolic and endocrine effects of the desogestrel-containing oral contraceptive Mircette.","volume":"179","author":"Berga","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R17-13-20210126","first-page":"63","article-title":"Clinical experience of a combined oral contraceptive with very low dose ethinyl estradiol.","volume":"164","author":"Akerlund","year":"1997","journal-title":"Acta Obstet Gynecol Scand Suppl"},{"key":"R18-13-20210126","first-page":"98","article-title":"Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.","volume":"40","author":"Teichmann","year":"1995","journal-title":"Int J Fertil Menopausal Stud"},{"key":"R19-13-20210126","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/AOG.0b013e3181875b78","article-title":"Effects of depot medroxyprogesterone acetate and 20-microgram oral contraceptives on bone mineral density.","volume":"112","author":"Berenson","year":"2008","journal-title":"Obstet Gynecol"},{"key":"R20-13-20210126","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0002-8223(21)07997-9","article-title":"Sources of data for developing and maintaining a nutrient database.","volume":"88","author":"Schakel","year":"1988","journal-title":"J Am Diet Assoc"},{"key":"R22-13-20210126","article-title":"Diet History Questionnaire (DHQ).","year":"2000"},{"key":"R23-13-20210126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang","year":"1986","journal-title":"Biometrika"},{"key":"R24-13-20210126","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00006254-199211000-00014","article-title":"The new era in oral contraception: pills containing gestodene, norgestimate, and desogestrel.","volume":"47","author":"London","year":"1992","journal-title":"Obstet Gynecol Surv"},{"key":"R25-13-20210126","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1177\/106002809502907-817","article-title":"Desogestrel, norgestimate, and gestodene: the newer progestins.","volume":"29","author":"Kaplan","year":"1995","journal-title":"Ann Pharmacother"},{"key":"R26-13-20210126","first-page":"1034","article-title":"Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins.","volume":"81","author":"Speroff","year":"1993","journal-title":"Obstet Gynecol"},{"key":"R27-13-20210126","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/0002-9378(88)90201-3","article-title":"Cardiovascular effects of endogenous and exogenous sex hormones over a woman\u2019s lifetime.","volume":"158","author":"Knopp","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"R28-13-20210126","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.contraception.2008.09.002","article-title":"Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial.","volume":"79","author":"Cagnacci","year":"2009","journal-title":"Contraception"},{"key":"R29-13-20210126","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.contraception.2004.12.005","article-title":"Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism.","volume":"71","author":"Klipping","year":"2005","journal-title":"Contraception"},{"key":"R30-13-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/07315724.2008.10719668","article-title":"The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk.","volume":"27","author":"Fernandez","year":"2008","journal-title":"J Am Coll Nutr"},{"key":"R31-13-20210126","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1001\/jama.1993.03500040071040","article-title":"Triglyceride, high-density lipoprotein, and coronary heart disease. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease.","volume":"269","year":"1993","journal-title":"JAMA"},{"key":"R32-13-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ajog.2008.04.048","article-title":"Physiologic and psychologic symptoms associated with use of injectable contraception and 20 microg oral contraceptive pills.","volume":"199","author":"Berenson","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"R33-13-20210126","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.contraception.2008.01.002","article-title":"Hormonal contraceptive discontinuation patterns according to formulation: investigation of associations in an administrative claims database.","volume":"77","author":"Murphy","year":"2008","journal-title":"Contraception"},{"key":"R34-13-20210126","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0002-9378(98)70047-X","article-title":"Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.","volume":"179","author":"Rosenberg","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"R35-13-20210126","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0010-7824(98)00041-9","article-title":"Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Results of an international, multicenter, case-control study. World Health Organization Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.","volume":"57","year":"1998","journal-title":"Contraception"},{"key":"R36-13-20210126","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1161\/01.CIR.0000030940.73167.4E","article-title":"Long term use of contraceptive depot medroxyprogesterone acetate in young women impairs arterial endothelial function assessed by cardiovascular magnetic resonance.","volume":"106","author":"Sorensen","year":"2002","journal-title":"Circulation"},{"key":"R37-13-20210126","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ajog.2008.12.052","article-title":"Changes in weight, total fat, percent body fat, and central- to-peripheral fat ratio associated with injectable and oral contraceptive use.","volume":"200","author":"Berenson","year":"2009","journal-title":"Am J Obstet Gynecol"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200910000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:00:31Z","timestamp":1786039231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200910000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e3181b76bea","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}